166 related articles for article (PubMed ID: 24491927)
21. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
22. Targeted drug delivery for treatment and imaging of glioblastoma multiforme.
Stukel JM; Caplan MR
Expert Opin Drug Deliv; 2009 Jul; 6(7):705-18. PubMed ID: 19538036
[TBL] [Abstract][Full Text] [Related]
23. Development of a gene/drug dual delivery system for brain tumor therapy: potent inhibition via RNA interference and synergistic effects.
Lei C; Cui Y; Zheng L; Chow PK; Wang CH
Biomaterials; 2013 Oct; 34(30):7483-94. PubMed ID: 23820014
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
25. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
26. Drug delivery strategies for the treatment of malignant gliomas.
Allhenn D; Boushehri MA; Lamprecht A
Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
[TBL] [Abstract][Full Text] [Related]
27. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
[TBL] [Abstract][Full Text] [Related]
28. Application of cell encapsulation for controlled delivery of biological therapeutics.
Orive G; Santos E; Pedraz JL; Hernández RM
Adv Drug Deliv Rev; 2014 Apr; 67-68():3-14. PubMed ID: 23886766
[TBL] [Abstract][Full Text] [Related]
29. Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice.
Riondel J; Jacrot M; Fessi H; Puisieux F; Potier
In Vivo; 1992; 6(1):23-7. PubMed ID: 1352706
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
31. RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.
Malhotra M; Toulouse A; Godinho BM; Mc Carthy DJ; Cryan JF; O'Driscoll CM
Mol Biosyst; 2015 Oct; 11(10):2635-57. PubMed ID: 26135606
[TBL] [Abstract][Full Text] [Related]
32. Nanocarrier-based therapies for CNS tumors.
Patel TR
CNS Oncol; 2014 Mar; 3(2):115-22. PubMed ID: 25055017
[TBL] [Abstract][Full Text] [Related]
33. Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy.
Caraglia M; Marra M; Budillon A
Expert Opin Biol Ther; 2008 Jul; 8(7):1031-5. PubMed ID: 18549332
[TBL] [Abstract][Full Text] [Related]
34. Biomaterial-based technologies for brain anti-cancer therapeutics and imaging.
Orive G; Ali OA; Anitua E; Pedraz JL; Emerich DF
Biochim Biophys Acta; 2010 Aug; 1806(1):96-107. PubMed ID: 20406668
[TBL] [Abstract][Full Text] [Related]
35. Barriers to carrier mediated drug and gene delivery to brain tumors.
Huynh GH; Deen DF; Szoka FC
J Control Release; 2006 Jan; 110(2):236-259. PubMed ID: 16318895
[TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors?
Brioschi A; Zenga F; Zara GP; Gasco MR; Ducati A; Mauro A
Neurol Res; 2007 Apr; 29(3):324-30. PubMed ID: 17509234
[TBL] [Abstract][Full Text] [Related]
37. Cell encapsulation technology as a therapeutic strategy for CNS malignancies.
Visted T; Bjerkvig R; Enger PO
Neuro Oncol; 2001 Jul; 3(3):201-10. PubMed ID: 11465401
[TBL] [Abstract][Full Text] [Related]
38. Macrophages as nanoparticle delivery vectors for photothermal therapy of brain tumors.
Christie C; Madsen SJ; Peng Q; Hirschberg H
Ther Deliv; 2015 Mar; 6(3):371-84. PubMed ID: 25853311
[TBL] [Abstract][Full Text] [Related]
39. Encapsulated cell therapy for neurodegenerative diseases: from promise to product.
Emerich DF; Orive G; Thanos C; Tornoe J; Wahlberg LU
Adv Drug Deliv Rev; 2014 Apr; 67-68():131-41. PubMed ID: 23880505
[TBL] [Abstract][Full Text] [Related]
40. Anti-SSTR2 peptide based targeted delivery of potent PLGA encapsulated 3,3'-diindolylmethane nanoparticles through blood brain barrier prevents glioma progression.
Bhowmik A; Chakravarti S; Ghosh A; Shaw R; Bhandary S; Bhattacharyya S; Sen PC; Ghosh MK
Oncotarget; 2017 Sep; 8(39):65339-65358. PubMed ID: 29029435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
